Limitations of Reporting Time Below Range as a Percentage

被引：9

作者：

Shah, Viral N. ^{[1
,2
]}

机构：

[1] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Aurora, CO USA

[2] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Aurora, CO 80045 USA

来源：

DIABETES TECHNOLOGY & THERAPEUTICS | 2023年 / 25卷 / 11期

关键词：

Type; 1; diabetes; 2; Time below range; CGM metrics; Hypoglycemia; Hypoglycemia event; METRICS;

D O I：

10.1089/dia.2023.0247

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Continuous glucose monitoring (CGM)-based metrics such as time in range and time below range (TBR) and their clinical targets are recommended along with glycated hemoglobin (A1c) to optimize diabetes care. CGM metrics are easy to understand by people with diabetes and have been widely accepted among health care providers. TBR, that is, time spent below a certain glucose level (e.g., <70 mg/dL and <54 mg/dL), is expressed as a percentage. This brief report draws attention to some limitations of TBR when expressed as an integer percentage and highlights problems introduced by rounding-off of numerical values for TBR on ambulatory glucose profile and other reports from CGM and automated insulin delivery systems that may be misleading or incorrectly interpreted. The goal of this article is to generate more discussion around reporting of TBR in ways that can be clinically impactful for people living with diabetes, health care providers, regulatory agencies, and payers to stratify and predict severe hypoglycemic events.

引用

页码：822 / 825

页数：4

共 10 条

[1] 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022 [J].

American Diabetes Association Professional Practice Committee .

DIABETES CARE, 2022, 45 :S83-S96

[2]

American Diabetes Association, TIM RANG

[3] Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes [J].

Amiel, Stephanie A. ;

Aschner, Pablo ;

Childs, Belinda ;

Cryer, Philip E. ;

de Galan, Bastiaan E. ;

Heller, Simon R. ;

Frier, Brian M. ;

Gonder-Frederick, Linda ;

Jones, Timothy ;

Khunti, Kamlesh ;

Leiter, Lawrence A. ;

McCrimmon, Rory J. ;

Luo, Yingying ;

Seaquist, Elizabeth R. ;

Vigersky, Robert ;

Zoungas, Sophia .

DIABETOLOGIA, 2017, 60 (01) :3-6

[4] Continuous glucose monitoring and metrics for clinical trials: an international consensus statement [J].

Battelino, Tadej ;

Alexander, Charles M. ;

Amiel, Stephanie A. ;

Arreaza-Rubin, Guillermo ;

Beck, Roy W. ;

Bergenstal, Richard M. ;

Buckingham, Bruce A. ;

Carroll, James ;

Ceriello, Antonio ;

Chow, Elaine ;

Choudhary, Pratik ;

Close, Kelly ;

Danne, Thomas ;

Dutta, Sanjoy ;

Gabbay, Robert ;

Garg, Satish ;

Heverly, Julie ;

Hirsch, Irl B. ;

Kader, Tina ;

Kenney, Julia ;

Kovatchev, Boris ;

Laffel, Lori ;

Maahs, David ;

Mathieu, Chantal ;

Mauricio, Didac ;

Nimri, Revital ;

Nishimura, Rimei ;

Scharf, Mauro ;

Del Prato, Stefano ;

Renard, Eric ;

Rosenstock, Julio ;

Saboo, Banshi ;

Ueki, Kohjiro ;

Umpierrez, Guillermo E. ;

Weinzimer, Stuart A. ;

Phillip, Moshe .

LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (01) :42-57

[5] Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].

Battelino, Tadej ;

Danne, Thomas ;

Bergenstal, Richard M. ;

Amiel, Stephanie A. ;

Beck, Roy ;

Biester, Torben ;

Bosi, Emanuele ;

Buckingham, Bruce A. ;

Cefalu, William T. ;

Close, Kelly L. ;

Cobelli, Claudio ;

Dassau, Eyal ;

DeVries, J. Hans ;

Donaghue, Kim C. ;

Dovc, Klemen ;

Doyle, Francis J. ;

Garg, Satish ;

Grunberger, George ;

Heller, Simon ;

Heinemann, Lutz ;

Hirsch, Irl B. ;

Hovorka, Roman ;

Jia, Weiping ;

Kordonouri, Olga ;

Kovatchev, Boris ;

Kowalski, Aaron ;

Laffel, Lori ;

Levine, Brian ;

Mayorov, Alexander ;

Mathieu, Chantal ;

Murphy, Helen R. ;

Nimri, Revital ;

Norgaard, Kirsten ;

Parkin, Christopher G. ;

Renard, Eric ;

Rodbard, David ;

Saboo, Banshi ;

Schatz, Desmond ;

Stoner, Keaton ;

Urakami, Tatsuiko ;

Weinzimer, Stuart A. ;

Phillip, Moshe .

DIABETES CARE, 2019, 42 (08) :1593-1603

[6] The Relationship Between Percent Time <70 mg/dL and Percent Time <54 mg/dL Measured by Continuous Glucose Monitoring [J].

Beck, Roy W. ;

Raghinaru, Dan ;

Calhoun, Peter ;

Bergenstal, Richard M. .

DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (03) :157-160

[7] Prediction of severe hypoglycemia [J].

Cox, Daniel J. ;

Gonder-Frederick, Linda ;

Ritterband, Lee ;

Clarke, William ;

Kovatchev, Boris P. .

DIABETES CARE, 2007, 30 (06) :1370-1373

[8] Factors Predictive of Severe Hypoglycemia in Type 1 Diabetes Analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset [J].

Fiallo-Scharer, Rosanna ;

Cheng, Jing ;

Beck, Roy W. ;

Buckingham, Bruce A. ;

Chase, H. Peter ;

Kollman, Craig ;

Laffel, Lori ;

Lawrence, Jean M. ;

Mauras, Nelly ;

Tamborlane, William V. ;

Wilson, Darrell M. ;

Wolpert, Howard ;

Bode, Bruce ;

Ruedy, Katrina J. ;

Weinzimer, Stuart ;

Xing, Dongyuan .

DIABETES CARE, 2011, 34 (03) :586-590

[9] American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus [J].

Grunberger, George ;

Sherr, Jennifer ;

Allende, Myriam ;

Blevins, Thomas ;

Bode, Bruce ;

Handelsman, Yehuda ;

Hellman, Richard ;

Lajara, Rosemarie ;

Roberts, Victor Lawrence ;

Rodbard, David ;

Stec, Carla ;

Unger, Jeff .

ENDOCRINE PRACTICE, 2021, 27 (06) :505-537

[10] Metrics to Evaluate Quality of Glycemic Control: Comparison of Time in Target, Hypoglycemic, and Hyperglycemic Ranges with "Risk Indices" [J].

Rodbard, David .

DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (05) :325-334

← 1 →